key: cord-0743903-9wrgih0h
authors: Maiti, Amit K
title: Evolutionary Shift from Purifying Selection towards Divergent Selection of SARS-CoV2 Favors its Invasion into Multiple Human Organs
date: 2022-02-15
journal: Virus Res
DOI: 10.1016/j.virusres.2022.198712
sha: 63365d28f9ab18ef9bb89e1b59f876a7f99b987e
doc_id: 743903
cord_uid: 9wrgih0h

SARS-CoV2 virus is believed to be originated from a closely related bat Coronavirus RaTG13 lineage and uses its key entry-point residues in S1 protein to attach with human ACE2 receptor. SARS-CoV2 could enter human from bat with its poorly developed entry-point residues much before its known appearance with slower mutation rate or recently with efficiently developed entry-point residues with higher mutation rate or through an intermediate host. Temporal analysis of SARS-CoV2 genome shows that its nucleotide substitution rate is as low as 27nt/year with an evolutionary rate of 9x10(−4)/site/year, which is well within the range of other RNA virus (10(−4) to 10(−6)/site/year). TMRCA of SARS-CoV2 from bat RaTG13 lineage appears to be in between 9-14 years. Evolution of a critical entry-point residue Y493Q needs two substitutions with an intermediate virus carrying Y493H (Y>H>Q) but has not been identified in known twenty-nine bat CoV virus. Genetic codon analysis indicates that SARS-CoV2 evolution during propagation in human disobeys neutral evolution as nonsynonymous mutations surpass synonymous mutations with the increase of ω (d(n)/d(s)). Taken together, genetic data suggests that SARS-CoV2 is originated long time back before its appearance in human in 2019. Increase of ω signifies that SARs-CoV2 evolution is approaching towards diversifying selection from purifying selection predictably for its infection power to evade multiple human organs.

Novel coronavirus SARS-CoV2 is believed to be originated in Wuhan, China in 2019 and has genomic identities to earlier SARS-COV virus with 79.8% and with MERS-COV virus with 59.1% (Ren, Wang et al. 2020 , Zhou, Yang et al. 2020 ). SARS-CoV2 shows highest homology with bat CoV virus RmYNO2 for most of the genome whereas shows weak homology with RBD region (Zhou, Chen et al. 2020) . Comparing highest identities of SARS-CoV2 genome with related CoV virus genome of Bat (ZC-45 (87.7%), RaTG13 (96.3%)), Pangolin (Pan-SL_CoV_GD (Guangdong, China) (91.2%), Pan_SL_CoV_GX (Guanxhi) (85.4%)), Li et al (Li, Giorgi et al. 2020) proposed that SARS-CoV2 arose from bat RaTG13 after gaining three insertions in the vicinity of RBM (Receptor Binding Motif) at RBD (Receptor Binding Domain) in S1 region by exchanged recombination with Pan_SL_COV_GD of pangolin. Due to higher dissimilarities with Pan-SL_CoV_GD in other genes except RBD of S1 protein, they suggested that pangolin could not be an intermediate host of SARS-CoV2 but RatG13 of bat (Rhinolophus affinis) is the most probable ancestors of SARS-CoV2 of human and, this views are supported by several phylogenetic studies (Forster, Forster et al. 2020 , Gonzalez-Reiche, Hernandez et al. 2020 , Latinne, Hu et al. 2020 . Mainly based on the presence of furin cleavage site (PRRA motif) in SARS-CoV2 that is not observed in any other CoV virus, although present in some beta coronavirus ), Andersen et al (2020) suggested that SARS-CoV2 was originated naturally from the homologue of SARS-CoV2 that was circulating long time in the bat along with RaTG13 and, had a common ancestor (Andersen, Rambaut et al. 2020) . However, recent analysis assumes that RTAG13 lineage rather than RATG13 alone could be common ancestor of SARS-CoV2 (Holmes, Goldstein et al. 2021) .

3 S (spike) protein of SARS-CoV2 virus resides on their protein coat membrane and is cleaved into two small proteins S1 and S2 by the human host enzymes. The cleavage occurs at the two sites: one in between S1/S2 site by furin and other in S2 site by a serine protease, TMPRSS2 ). S1 forms a claw like structure with seven key entry-point residues 449Y, 455L, 486F, 489Y, 493Q, 500T and, 501N at the RBM and, attaches with K31, E35, D38, M82 and K353 of the host ACE2 (Angiotensin Converting Enzyme 2) receptor (Wan, Shang et al. 2020 whereas S2 mediates membrane fusion with the host cell. Among these residues K31-493Q and K353-501N interactions are most important for SARS-CoV2 infection to human host and, provide more chemically favorable interactions than SARS-COV K31-479L/N (homologue of SARS-CoV2 493Q) and K353-487S/T (homologue of 501N) binding, which gave SARS-CoV2 more infection power over SARS-COV (Wan, Shang et al. 2020) .

Apart from uncertainty about the origin of SARS-CoV2, evidences are accumulating that RaTG13 of bat is zoonotically evolved to SARS-CoV2 of human without the recombination of RBD of S1 protein region (Boni, Lemey et al. 2020 ) and, remains as a significant ancestral lineages of SARS-CoV2. Thus, an attempt to estimate evolutionary time frame, TMRCA (Time from Most Common Recent Ancestor) from its nearest ancestor RaTG13 could give an insight into SARS-CoV2 origin which could even be longer if both share a common unknown ancestor.

Estimating the TMRCA to evolute SARS-CoV2 from RaTG13 is intricate and, depends on mutation rate with other factors. Especially, the RNA virus evolution is complicated as it depends on the forces that drive the mutation rate per site nucleotide in the genome for its extra step of reverse transcription (Temin 1989) . The optional mutation rate is context dependent at which rate the errors are made during replication of the viral genome. Apart from depending on the size of the genome, it also depends on the fidelity of RDRP (RNA Directed RNA Polymerase), proofreading activity and, selection pressure (Peck and Lauring 2018) . Although, all RNA virus RDRP do not possess proofreading activities, but Coronavirus have strong proofreading activities with very 4 different sequences. As for example, SARS-CoV2 and Ebola RDRP are completely different (no significant similarities, data not shown) although SARS-CoV2 RDRP bears considerable identities with SARS-COV (Ren, Wang et al. 2020 , Zhou, Yang et al. 2020 ). Thus, a general consensus about a mutation rate in SARS-CoV2 cannot be reached although the mutation rate for positive strand RNA virus have been estimated as 10-4 to 10-6/s(substitution)/n(nucleotide)/c (cell infection). Cell infection estimates the viral generation (Holmes 2009 , Sanjuán, Nebot et al. 2010 , Peck and Lauring 2018 .

The estimation of evolutionary time, TMRCA, from genetic data mostly are fitted to molecular clock theory (Zuckerkandl and Pauling 1965) and later refined by neutral theory of evolution (Kimura 1979) . For RNA virus evolution, the neutral theory based on strict molecular clock appears to be correct for influenza A virus (Gojobori, Moriyama et al. 1990 ). Although, HIV1 evolution initially rejected the neutral theory (Posada and Crandall 2001) but removal of datasets carrying recombination event from the nucleotide data showed HIV evolution also followed strict molecular clock (Liu, Nickle et al. 2004) . In oppose to molecular clock theory, rate of molecular evolution can vary over time and strict molecular clock can fail due to vast data (Lee, Rodrigue et al. 2015) and in such cases, relaxed molecular clock could be fitted. However, such relaxed molecular clock ) like rate smoothing method (Sanderson 2002) , Bayesian methods (Thorne, Kishino et al. 1998 , Huelsenbeck, Larget et al. 2000 , Drummond and Suchard 2010 , likelihood distribution (Felsenstein 1981 , Paradis, Tedesco et al. 2013 or partitioned molecular clock (Thorne, Kishino et al. 1998 ) have been widely used especially for phylogenetic separation of species. Local clocks (Yoder and Yang 2000) or molecular dating (Lepage, Bryant et al. 2007) techniques are also choice of methods that are used for species separations.

Here, we estimated the evolutionary rate of SARS-CoV2 virus in human by analyzing the nucleotide base substitutions of one sixty-six SARS-CoV2 genome from December 2019 to September 2020 in temporal manner.

Comparing the evolutionary rate by synonymous amino acid changes following neutral evolution, we estimated that it would take approximately 9-14 years to appear as SARS-CoV2 in human from RaTG13 lineage of bat.

Detail analysis of nucleotide evolution of RBD of S protein does not support recombination of S1 RBD region from Pan_SL_CoV_GD. Evolution of a key entry-point residue Y493Q indicates that Y must be mutated twice to give rise to Q as Y>H>Q but such an intermediate CoV virus is never identified in known twenty-nine bat CoV virus. Comparing the changes in genetic codons of synonymous and nonsynonymous amino acids we also show that SARS-CoV2 evolution from RaTG13 lineage followed strict molecular clock with neutral evolution but after its appearance in human, SARS-CoV2 does not follow strict neutral evolution. As the infection time progresses, the increase of ω (d n /d s , the rate of the proportion of nonsynonymous mutations to the synonymous mutations) value indicates that SARS-CoV2 is proceeding towards divergent selection from purifying selection predictably with the invasion of multiple organs of the human body before reaching saturation or equilibrium. recorded for each sequence and, these viral genomes are grouped by their collection date within 1 st and 10 th of each month to use for analysis so that sequences should represent gaps of at least approximately of one month. Also, in each month group, SARS-CoV2 genomes were collected from different places in the world to maintain diversification.

Evolutinary tree are constructed and TMRCA was determined using BEAST v1.10.4 package (Drummond and Rambaut 2007 , Drummond, Suchard et al. 2012 , Rambaut, Drummond et al. 2018 

Virus genome sequences are compared for identity differences using 2-nucleotide blasts (Needleman-Wunsch Global Align Nucleotide Sequences) at the NCBI website using the SARS-CoV2 reference genome (NC_045512, Wuhan-Hu-1). This genome has 100% identity with the genome that was collected on 12/01/2019 (MN908947). From the blast results the numbers of nucleotide identity differences are noted or counted removing the gaps and, other artifacts in alignments [Supplementary Table 1 ]. Average nucleotide differences are calculated for each month by using mean differences in nucleotides of all the genome collected in that month.

Average nucleotide difference of a month group over the average nucleotide difference of previous month is considered as the base substitution rate in that month. Statistical significance (p<0.05) is calculated by students' ttest for synonymous vs nonsynonymous amino acid (aa) changes by the nucleotides (nt) for each month. 

The evolutionary rate per site of SARS-CoV2 genome is estimated following three substitution model (3ST) (Kimura 1981) . SARS-CoV2 genome of 29903nt mostly has coding sequences of 29244nt that codes for 9748aa. 

Evolutionary time of SARS-CoV2 from RaTG13 is estimated using neutral evolution (Kimura 1979) and (Nei and Gojobori 1986) . For synonymous codons, α, ß, Γ, and for nonsynonymous codons α1, ß1 and Γ1 are calculated as earlier during estimation of evolutionary rate calculation for SARS-CoV2 in human. The total base substitution for each position at the codon are calculated using the same formula for neutral evolution K= -

and the K corresponds to 0.0018, 0.0069 and 0.08 for 1 st , 2 nd and 3 rd codon respectively [Supplementary Table 3 ].

The evolutionary time frames, TMRCA are calculated using the evolutionary rate in each codon position that had been earlier estimated for SARS-CoV2 in human (knuc for 1 st codon position, 0.00178/site/year, for 2 nd position, 0.00185/site/year and for 3 rd position, 0.00467/site/year) by using same formula for neutral evolution,

K=2Tknuc.

Hence, by using same formula (T=K/2knuc), we determined T, the time taken to evolute 1 st codon corresponds to 3.3 years (=0.0018/2*0.0018), 1.9 years (0.0069/2*0.00178) and for 3 rd codon position 9.57 years (0.08/2* 0.00467).

Synonymous and nonsynonymous amino acid changes are estimated according Nei and Gozobori (1986) (Nei and Gojobori 1986) with Zukes and cantor (1969) (Zukes and Cantor 1969) , Yang and Nelson (2000) (Yang and Nielsen 2000) and Li et al (1986) (Li, Wu et al. 1985) . These estimations were essentially done using software PAML (phylogenetic Analysis by Maximum Likelihood; https://abacus.gene.ucl.ac.uk/software/paml.html).

Although all methods gave similar values for ω, we focused on Nei and Gojobori (1986) For ω analysis of RBD domain of S1 protein region of human SARS-CoV2, bat RaTG13 and pangolin Pan_SL_COV_GD, the amino acid sequences of (438-506aa) are calculated and compared in PAML.

10 Alignments of ACE2 protein sequences from all animals and S1 protein region of RBD are done using CLUSTALW at https://npsa-prabi.ibcp.fr/. Although the exact ancestor of SARS-CoV2 is currently unknown but the RaTG13 lineage in bat CoV virus is likely to be its probable ancestor. The phylogenetic tree based on whole genomic sequences of most related bat CoV virus, RaTG13, SL_ZC45, SL_ZXC21, RmNo2 and Pan_GD (Pangolin CoV virus, Pan_SL_CoV_GD)

suggests that SARS-CoV2 is separated most recently and bears highest similarities with RaTG13 [ Fig. 1a] .

Moreover, both strict and relaxed molecular clock model constructed similar tree with very little branching differences emphasizing SARS-CoV2 evolution could be traced with strict molecular clock [Fig. 1b, c] . Similarly, TMRCA of SARS-CoV2 appears to be ~40 years from the most recent ancestors with evenly distributed coalescent time [Fig 1c, nonsynonymous amino acid changes. It is noted that in January, 2020 isolates when SARS-CoV2 in its initial phase of emergence, the synonymous and nonsynonymous aa changes are not significant (p=0.23)

[Supplementary Table 4A ]. After January, in all months until September, 2020 p-values are highly significant (p<0.05). Although this apparent discrepency is unknown, the greater synonymous aa changes over nonsynonymous aa changes emphasizes that SARS-CoV2 evolution is following the neutral evolution with strict molecular clock, which assumes that substitution rate will be equal to the mutation rate (Kimura 1979 (Duchêne, Holmes et al. 2014) suggested that the evolutionary time-scales in RNA viruses require to consider substitution rates as a dynamic, rather than as a static, especially when molecular data sampled over a short timeframe that are often appear to evolve at higher rates than those sampled over a longer time period. The inadequate 'correction' of multiple substitutions at single nucleotide sites is necessary to explain the evolutionary time-scale of a RNA virus, hence three orders of magnitude lower than that estimated using virus samples should be used (Worobey, Telfer et al. 2010, Ho and . Thus, after all corrections, it would take approximately 13.6 (40.96/3) years to evolve SARS-CoV2 from RaTG13 lineage or more from a common ancestor at the rate of evolution that are occurring in present day SARS-CoV2 virus in human.

Molecular clock based on neutral evolution suggests that synonymous mutations that are not in a selection constraint always must be greater than nonsynonymous mutations (Kimura 1979 , Gojobori, Moriyama et al. 1990 ).

As the synonymous amino acid changes are nonconstrained, the spontaneous nucleotide changes at the 3 rd position of a codon that leads to mostly synonymous amino acid changes and, that would be greater than the evolutionary 14 rate of other two positions of the codon (72%) (1 st position gives 5% and 2 nd position is zero as all 2 nd position nt changes gives rise to nonsynonymous mutation) (Nei and Gojobori 1986) . We estimated the evolutionary rate of SARS-CoV2 genomes in human in September isolates (1 st -10 th ) in comparing with SARS-CoV2 reference genome (NC_045512) by counting the synonymous and nonsynonymous amino acid changes. This enables that the nucleotide changes are preserved in the population after 9 months of propagation from its appearance in December 2019 and the proportion of synonymous to nonsynonymous changes are maintained. In contrast, random mutation counting would include any nt changes in these months without considering deleterious nonsynonymous mutation in a strain also abolishes synonymous mutations. For both synonymous and nonsynonymous aa, the nt changes in 3 rd position is significantly higher than 1 st (p hsyn -3rd-1st = 2.24E-43; p hnonsyn-3rd-1st = 1.17028E-07 or 2 nd (p hsyn-3rd-2nd =0;

p hnonsyn-3rd -2nd = 3.24E-07) position of the codon (Supplementary Table 4B 

We calculated the TMRCA to evolute SARS-CoV2 from RaTG13 lineage that would provide insight into the origin of SARS-CoV2. For comparing mismatch nucleotide sequences between two virus and estimation of TMRCA using strict molecular clock following neutral evolution, we excluded S protein region from the whole genomic sequences of SARS-CoV2 and RaTG13 virus as this region is ambiguously believed to be inserted by recombination from Pan_SL_CoV_GD (Li, Giorgi et al. 2020 ). In addition, Liu et al (2004) (Liu, Nickle et al. 2004) showed that when recombination regions were removed from dataset, HIV1 evolution based on only mismatch nucleotide analysis 15 exactly followed strict molecular clock. We considered SARS-CoV2 poly 1ab gene (266nt-21555nt, 7097aa)

including RDRP gene for estimating synonymous and nonsynonymous changes of amino acids among 7096 aa (one is omitted due to a codon insertion). Total 689 aa are changed and comparable with 106aa and 583 aa are nonsynonymous and synonymous aa respectively. The synonymous aa changes are also much and significantly higher (583/106=5.5; p= 2. 0839E-197) [Supplementary Table 4B ] than nonsynonymous aa changes and, could be fitted to strict molecular cloak (Kimura 1979) . The NT changes in 3 rd position of the codon for both synonymous and nonsynonymous aa are to 1 st (p rsyn -3rd-1st= 1.77E-304; p rnonsyn-3rd-1st= 0.00062184) and 2 nd (p rsyn-3rd-2nd =0; p rnonsyn-3rd - It is notable that if RBD domain of S1 protein (sp) had come from pangolin virus into SARS-CoV2, Pan_SL_CoV_GD by recombination and then accumulated mutation, the ω value is very low (ω <0.0078) compared to other conversion implying that RBD region might originated zoonotically from RATG13 of bat. c) Sudden increase of ω implying increase of nonsynonymous substitution over synonymous substitution in SARS-CoV2 during human propagation. d) Alignment of five key entry point residues in ACE2 protein of various animals. SARS-CoV2 shows poor infectivity due to absence of K353 residue in mouse and rat (shown in blue box).

codon are estimated using the knuc value [ Fig.4a ] that are obtained for SARS-CoV2 evolution in human for each position and are 3.31 years, 1.9 years and 9.6 years respectively. As the 3 rd codon replacements mostly (72%) stands for synonymous aaa changes (Nei and Gojobori 1986 ) and evolution under zero constraints, 13.3 years ((9.6/72) X 100) could be an reasonable TMRCA to arise SARS-CoV2 from RaTG13 or more than 9.6-13.3 years from an unknown ancestor of both of them. However, this time frame is in close approximation of 13.6 years that has been estimated by using strict molecular clock using base substitution model, Thus, TMRCA determination by three independent ways (direct determination by base substitution rate, codon replacement and whole genomic sequence by BEAST software using strict and relaxed molecular clock) points out similar timeframe for SARS-CoV2 emergence (9.6-13.6) years.

We estimated the proportion of synonymous and nonsynonymous differences, ω (dn/ds) in SARS-CoV2 in human propagation and from RaTG13 to SARS-CoV2 evolution. Although the ω is below (1< ω) in both the cases [ Fig   4b] for RaTG13-SARS-CoV2 (ω-rtg13-sars =0.04) and SARS-CoV2 in human (ω-sars-hu=0.30) [Fig 4c] signifying purifying or negative selection, but they have large differences in values. In fact, SARS-CoV2 in human has more than 7 fold (ω-sars-hu/ ω-rtg13-sars=0.30/0.04=7.5) higher ω value than RaTG13-SARS-CoV2 implying that selection constraints are tremendously driving the SARS-CoV2 evolution in human from purifying selection towards diversifying selection (approaching ω >=1) (Yang and Bielawski 2000) . The purifying selection often could be a force for viral evolution as they proceed towards fixation by deleting the nonsynonymous and deleterious mutations (Kryazhimskiy and Plotkin 2008) (Lin, Bhattacharjee et al. 2019) and, it appears that SARS-CoV2 is proceeding such evolutionary .trajectories towards diversifying selection.

RBD (438aa-506aa) of S1 protein contains key entry-point residues to attach human ACE2 receptor in SARS-CoV2 and, is believed to be originated from recombination from the Pan_SL_CoV_GD (Li, Giorgi et al. theory states that the rate of synonymous or silent substitutions is usually larger than that of nonsynonymous (i.e., amino acid-altering) substitutions (Gojobori, Moriyama et al. 1990 respectively) in this region in SARS-CoV2 (Islam, Hoque et al. 2020 , Long, Olsen et al. 2020 . Nevertheless, when ω is calculated for this region of S1 protein (438aa-506aa), the Pan_SL_CoV_GD (after recombination followed by natural synonymous mutation) shows very low value (ω =0.008) than other conversions [Fig4b, Supplementary In addition, the concept of recombination in this region of S1 protein from Pan_SL_CoV_GD ambiguously determined with Simplot analysis (Li, Giorgi et al. 2020 ) meant for similar sequence identification but not recombination although (Wu, Zhao et al. 2020) , who first noted recombination of this region compared only several bat CoV virus with SARS-CoV2 but not with any pangolin CoV virus. Moreover, using extensive recombination breakpoint analysis at the S1 protein of SARS-CoV2, Pan_SL_CoV_GD and other bat coronavirus, Boni et al (2020) (Boni, Lemey et al. 2020) and Maclean et al (MacLean, Lytras et al. 2021 ) recently showed that S1 RBD region is unlikely came from Pan_SL_CoV_GD by recombination, instead, SARS-CoV2 naturally evoluted from RaTG13 or other related bat virus.

21 SARS-CoV2 virus uses key entry-point residues of RBD in S1 protein to bind with the ACE2 receptor of human through K31, E35, D38, M82 and, K353 (Wan, Shang et al. 2020 ). Among them, K31 and, K353 of ACE2 are the most important residues for effective SARS-CoV2 binding. Analysis of these residues in ACE2 receptors in various animals suggests that mouse and, rat possess poor ACE2 receptors (H353 instead of K353; also, mouse has N31 instead of K31) [ Fig. 4d ] (Wan, Shang et al. 2020 

K353-501N attachment site of human ACE2-SARS-CoV2 is the most efficient and crucial entry-point. In

RaTG13 of bat from where SARS-CoV2 is believed to be originated, the homologue at 501N position is aa D (code GAU). An amino acid changes from D (code GAU) to N (code AAU) at this position in SARS-CoV2 enables them to infect human host. Thus, a single substitution in 1st codon from G>A nucleotide could give rise aaN from aaD at the 501 position in the RBD of SARS-CoV2 for K353-501N salt bridge formation for important attachment site and, almost gave RaTG13 a passport to infect human efficiently. Very recently it is proposed that 486F residue could be highest energetic contributor for SARS-COV2 binding (Liu, Hu et al. 2021 ) , a series of crystalographic and modelling reports , Zhu, Mannar et al. 2021 suggests that 493 and 501 are most important residues for SARS-CoV2 attachment to ACE2 receptor. Especially in the evolutionary point of view all 22 SARS-CoV2 virulent strains (alpha, beta, gamma, delta) contains a new mutation in 501 residue with more infective power.

Similarly, 493Q residue in SARS-CoV2 for K31-493Q interaction, which is the second most important entry-point attachment is evolved from amino acid Y, which is present in RaTG13 of bat. However, Y is coded by UAU and to become Q (code CAA) of SARS-CoV2, the codon needs to mutate at least twice i.e., mutation in two nucleotides in 1st and 3rd codon. The 1st codon must be U>C mutation and the second mutation at the 3rd codon could be U>A.

If the 3rd codon mutation occurred earlier than 1st codon mutation in the bat virus, it would lead to nonsense ( (Forster, Forster et al. 2020 , Latinne, Hu et al. 2020 , Li, Giorgi et al. 2020 ) but no such ancestral viral strain was identified with a 493H in RBD. Although the etiology of predicted 493H binding affinity with K31 of ACE2 receptor is unknown but presumed to have some binding activities because it had to be existed before transforming to be a 493Q residue. The possibility of simultaneously arising double mutation can not be ruled out but the probability of such a double mistake in a replication cycle in two neighboring nucleotides is extremely rare. 493H carrying region might come from Pan_SL_CoV_GD by recombination as believed by Li et al (Li, Giorgi et al. 2020 ) but the recombination event is ambiguously projected as it is ruled out (Boni, Lemey et al. 2020 ). Nevertheless, it assumes that similar transformation of 493 Y>H>Q must occurred in pangolin. Thus, beside bat, there should be a SARS-CoV2 ancestor virus carrying 493H that remains to be identified unless the existence of such an ancestor virus still could be explored in bat.

For other remaining entry-point residues of 449Y, 455L, 486F, 489Y and 500T, three residues 455L, 489Y

and 500T of SARS-CoV2 did not need any nucleotides substitutions. But 449Y of SARS-CoV2 needs a single nucleotide substitution from bat RATG13 (aa F>aa Y, UUU > UAU, 2 nd codon, U>A). Similarly, for 486F (aaL > aaF, CUA >CUU, 3 rd codon A>U) . Thus, in 449Y and 486F both cases, a single nucleotide substitution from bat also could give rise to these SARS-CoV2 entry-point residues.

Effective vaccines or medicines development and, testing them in animals, it is necessary to know the origin of this virus and, how it is behaving in the human population by changing their genetic profile with evolutionary dynamics. The creation of new mutations with evolutionary trajectories driving these pandemic could be replicated in vitro that could predict the reversion of vaccine effect and, its virulency as shown in other RNA virus (Stern, Yeh et al. 2017 ).

Most of the RNA virus followed neutral evolution with strict molecular clock, such as Influenza A virus (Gojobori, Moriyama et al. 1990) , HIV1 virus (Liu, Nickle et al. 2004 ), Rous sarcoma virus and Herpes simplex virus (Sanjuán, Nebot et al. 2010 ). As we observed synonymous aa changes are much greater in both SARS-CoV2 in human than from RaTG13 lineage-SARS-CoV2, the evolution of these viruses is predictably following neutral evolution with strict molecular clock. Here we also did not consider any relaxed molecular clock as we did not compare here divergence of species from related bat coronavirus nor we focused on phylogenetic relationship with other related virus. Although, it follows neutral evolution, the impact of phenotypic changes of less nonsynonymous changes over synonymous aa are much greater in the evolutionary context of evolution. Our analysis suggests that the mutation rate of SARS-CoV2 (~9.0 X 10-4/site/year) is slightly lower than other RNA virus as it has been estimated as in the order of 10-3 to 10-4/site/year (E.C. 2009 , Duchêne, Holmes et al. 2014 or 10-4 to 10-6 /site/nucleotide/cell infection (Peck and Lauring 2018) . In HIV1 Virus, the mutation rate for synonymous and 24 nonsynonymous amino acid changes are (13.2 X10-3/site/year) and, (6.9 X 10-3/site/year) respectively (Li, Tanimura et al. 1988) [ Figure 3d ].

It is surprising that SARS-CoV2 appears to be undergoing higher number of generations as it created pandemic in world human population, yet the mutation rate is lower than other RNA viruses. Thus SARS-CoV2 mutation rate could be better explained by the rate upon context dependent (Peck and Lauring 2018) . Mutation frequency can be confounded by selection and genetic drift. In that case mutation rate could be lowered as the deleterious mutation drives the mutation rate lower as a principle criteria for purifying or negative selection (Peck and Lauring 2018) . Between two models as speed vs adaptability of viral mutation rate, here it appears that SAR-COV2 evolution fits with adaptability model, which states that after a long adaptation to evade immune system, the selection pressure is relatively low and the supply of beneficial mutation frequency is reduced, thus population favors a low mutation rate. When the mutation reaches to an optimum level simply because selection is acting on it long time within the context of immune escape to reach the maximum mutation fitness (Orr 2000 , Sanjuán 2010 , Sanjuán, Nebot et al. 2010 , Peck and Lauring 2018 .

When purifying selection occurs in the population, the ω value is low (ω <1), but in case of higher value (ω =>1) significant divergent and aggressive evolution are warrant. The ω value from RaTG13 lineage-SARS-CoV2 evolution (ω =0.04) reached to much higher value (ω=0.30) after its appearance and, propagation in human suggesting that the virus is proceeding towards divergent selection (ω =>1) from purifying selection (ω =<1). A virus undergoes divergent selection when novel conditions are created by i) change of environment over short time,

ii) heterogenous environment with multiple niches (Elena and Sanjuán 2005) . SARS-CoV2 attaches with key entrypoint residues in ACE2 receptor that is highly expressed in pneumocytes in lung, endocytes in gut and nasal goblet cells but also expresses in almost all tissues in the human body with a moderate level (Ziegler, Allon et al. 2020 ).

Thus, SARS-CoV2 has ability to invade multiple organs having ACE2 receptor expressions and faces constant challenges from tissue specific immune surveillance with multiple niches of environmental conditions. Invasion of 25 SARS-CoV2 into various human organs is predictably increasing the nonsynonymous mutation over synonymous mutations that are persisted over the deleterious mutation and, increases its selection fitness Sanjuán 2005, Peck and Lauring 2018) . In vitro studies confirmed the attainment of high ω value for HIV1 env gene when propagated in multiple tissue specific propagation (Sanjuán, Codoñer et al. 2004 ). Indeed, it has been shown that the turnover rate of the type of infected cells (tissue specificity) is positively associated with the rate of HIV1 viral evolution (Hicks and Duffy 2014).

Our estimation of evolutionary time taken by the SARS-CoV2 from bat RaTG13 lineage using strict molecular clock based on phylogenetic model, base substitution model and neutral evolution are in close proximation of time frame of 9.6 years to 13.6 years. SARS-CoV2 might directly came from RaTG13 of bat or through intermediate host with efficient entry-point residues but highly adapted to replicate with slower mutation rate and, survive in a specialized immune system of the human body. After adaptation in human host, it gained more virulence by further substitution followed by selection pressure. Virulency of SARs-CoV2 is further evidenced by a strain containing D614G mutation believed to be the reason of widespread infection in USA and

Europe. This mutation creates an extra serine protease cleavage site at the S1/S2 junction of the spike protein and facilitate further infectivity in Caucasians with a Del C (rs35074065) genotypic background in the intergenic region between TMPRSS2 and MX1 gene (Korber, Fischer et al. 2020) . Zhang et al (2020) showed that 614G mutated protein reduces S1 shedding and increase infectivity (Zhang, Jackson et al. 2020 ). However, van Dorp et al (2020) (van Dorp, Richard et al. 2020) did not find any evidence of a particular strain of SARS-CoV2 that has overinfecting ability in the population although Long et al (2020) convincingly showed the widespread infectivity of this strain in southern USA population (Long, Olsen et al. 2020) ,.However, very recently a super-infective b.1.1.7 strain carries a set of spike protein mutations including D614G, N501Y and P681H (Rambaut, Loman et al. 2020 ).

This N501Y (AAT->TAT) conversion is believed to provide further stronger K353-501Y attachment to enable more infective power. P681H resides in the furin cleavage site in this strain predictably with improved function.

However, these three mutations were observed independently but not together in one strain like b. Based on phylogenetic analysis several reports suggests the emergence of RBD by recombination event from pangolin RBD. Similar phylogenetic and recombination breakpoint analysis also opposes the recombination event for RBD in SARS-CoV2 and suggests that it had originated naturally by mutation from its ancestor lineage (Boni, Lemey et al. 2020 , MacLean, Lytras et al. 2021 . Our detail analysis with nucleotide sequences does not support recombination event in RBD region in SARS-CoV2 and favors the view that RBD of SARS-CoV2 could naturally be evolved from its ancestor lineage.

Limitations in our study may involve a biased sampling of a particular variant strain that could represent repetitively over other low mutating strain or inclusion of a single genome consists of repeated mismatch. Also, we wanted to assess here the average mutation rate in SARS-CoV2 virus undergoing substitutions to evolve to become a better strain. Another important consideration is that we did not observe any recombination or big insertions in a 27 particular strain as frequent occurrence of those event could increase the mutation rate further. In September isolates, during substitution rate estimation, synonymous rate is higher than nonsynonymous mutations, but they are almost equal during evolutionary rate estimation as later is accounted for proportionate calculation in the same sequences. Lastly, we estimated the evolutionary rate of SARS-CoV2 in human host and, those values are used to calculate the TMRCA from bat RaTG13 lineage. Nevertheless, to take less time than our estimation time to evolute in bat than human (<9-14 years) could presume that bat system must have higher mutation rate than human which further assumes that it had to face much more challenging environment in bat than human. Although this is not expected as RaTG13 is a native virus (long time adaptation) or circulating in bat for long time (Andersen, Rambaut et al. 2020) in the same environment with same immune system. Although, the sequence analysis before the pandemic from RATG13 lineage is done with available sequences in nearest ancestor lineage of SARS-CoV2 (e.g.

RATG13) and the 1st SARS-CoV2 sequences, the analysis during the pandemic is performed in a short time scale in terms of evolutionary perspectives. However, earlier standardized suggestions (Sanjuán, Nebot et al. 2010, Sanjuán and Domingo-Calap 2016) are followed for evolutionary analysis in short time frame to obtain conclusion as accurate as possible. It is also true that demography specific selection pressure should made analysis complicated although has not been enquired here. Lastly, we estimated mutation rate using RATG13 as sequence as an ancestor of SARS-CoV2 although several studies support that RATG13 lineage rather than RATG13 alone could be the ancestor of SARS-CoV2 (Holmes, Goldstein et al. 2021 , MacLean, Lytras et al. 2021 . However, estimation here may not be accurate estimation for SARS-Cov2 emergence from contemporary lineage of its ancestors but provide a tractable time point from RATG13.

SARS-CoV2 evolution comprises any of these three possibilities: it entered human host from bat early with its poorly developed entry-point residues much before its known appearance and remained silent for long time with slower mutation rate to evade human immune system or recently with efficiently developed entry-point residues having more infective power but adapted with higher mutation rate or recently through an intermediate host having Furthermore, after its known appearance in human, it is proceeding towards aggressive and divergent selection predictably due to invasion into multiple organs in diverse population of the world. Due to excessive constrained immune and environmental challenges, SARS-CoV2 is evolving rapidly with proportionately more nonsynonymous aa changes over synonymous aa and is acquiring excessive selective fitness to be stable to create pandemic.

Moreover, nucleotide evolution suggests that SARS-CoV2 S1 RBD region is likely to be originated naturally from

RaTG13 of bat without the recombination of S1 RBD region from pangolin CoV virus.

Availability of data and material (data transparency):All data will be available after publication

Code availability (software application or custom code): Not applicable Authors' contributions: Amit K Maiti conceived the idea, analyzed and wrote the manuscript Ethics approval (include appropriate approvals or waivers):NA Consent to participate (include appropriate statements): All authors consent to participate Consent for publication: All author gave consent to publish AUTHOR STATEMENT I, Amit K Maiti, have full consent to publish this paper. There is no financial interest.

The proximal origin of SARS-CoV-2

Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic

BEAST: Bayesian evolutionary analysis by sampling trees

Bayesian random local clocks, or one rate to rule them all

Bayesian phylogenetics with BEAUti and the BEAST 1.7

Analyses of evolutionary dynamics in viruses are hindered by a timedependent bias in rate estimates

The evolution and emergence of RNA viruses

Adaptive value of high mutation rates of RNA viruses: separating causes from consequences

Evolutionary trees from DNA sequences: a maximum likelihood approach

Phylogenetic network analysis of SARS-CoV-2 genomes

Molecular clock of viral evolution, and the neutral theory

Introductions and early spread of SARS-CoV-2 in the New York City area

Cell tropism predicts long-term nucleotide substitution rates of mammalian RNA viruses

Molecular-clock methods for estimating evolutionary rates and timescales

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

RNA virus genomics: a world of possibilities

The origins of SARS-CoV-2: A critical review

A compound poisson process for relaxing the molecular clock

Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity

The neutral theory of molecular evolution

Estimation of evolutionary distances between homologous nucleotide sequences

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

The population genetics of dN/dS

Origin and cross-species transmission of bat coronaviruses in China

Relaxing the Molecular Clock to Different Degrees for Different Substitution Types

A general comparison of relaxed molecular clock models

Rates and dates of divergence between AIDS virus nucleotide sequences

A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes

Emergence of SARS-CoV-2 through recombination and strong purifying selection

Emergence of SARS-CoV-2 through recombination and strong purifying selection

Many human RNA viruses show extraordinarily stringent selective constraints on protein evolution

Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2

Molecular clock-like evolution of human immunodeficiency virus type 1

Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area

Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen

Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions

The rate of adaptation in asexuals

Quantifying variation in speciation and extinction rates with clade data

Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2

Complexities of Viral Mutation Rates

Selecting models of nucleotide substitution: an application to human immunodeficiency virus 1 (HIV-1)

Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7

CoG-UK) (2020). Preliminary genomic characterization of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

Estimating absolute rates of molecular evolution and divergence times: a penalized likelihood approach

Mutational fitness effects in RNA and single-stranded DNA viruses: common patterns revealed by sitedirected mutagenesis studies

Natural selection and the organ-specific differentiation of HIV-1 V3 hypervariable region

Mechanisms of viral mutation

Viral mutation rates

The Evolutionary Pathway to Virulence of an RNA Virus

Retrovirus variation and evolution

Estimating the rate of evolution of the rate of molecular evolution

No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Island biogeography reveals the deep history of SIV

A new coronavirus associated with human respiratory disease in China

Statistical methods for detecting molecular adaptation

Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models

Estimation of primate speciation dates using local molecular clocks

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies

Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Molecules as documents of evolutionary history

Mammalian protein metabolism III

Graphical Abstract

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

I am indebted to Dr. S. Gupta for critically reading the manuscript and U. Biswas for assistance in preparing the manuscript.